SynthesisEndocrine2024

Safety and efficacy of GLP-1 and glucagon receptor dual agonist for the treatment of type 2 diabetes and obesity: a systematic review and meta-analysis of randomized controlled trials.

Bixin Deng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.